An “F” for pharma at med schools

Most U.S. medical schools are granting too much access to pharmaceutical representatives, according to a scorecard released by the American Medical Student Association. The "AMSA 2007 PharmFree Scorecard" is part of the association's PharmFree Campaign to remove industry influence from medical practice. "A" grades - given to Stanford, UC Davis, University of Pennsylvania, University of Michigan and Yale - were given to schools with a "comprehensive policy that restricts pharmaceutical representatives' access to both the medical school campus and the Academic Medical Center." Eight schools received a "B," 23 a "C+," 13 a "C," 8 a "C-," and 19 a "D," and 40 schools were given "F" grades...